Background
The structure of human gastrointestinal mucosa is highly complex. The mucosal morphology and enzymatic function are reached mainly during mid-gestation, but the mucosa undergoes regeneration throughout life. The mature mucosa comprises multipotent stem cells, their immediate progeny, and various differentiated cell types that serve digestive, absorptive, or immunologic functions. The maintenance of mucosal homeostasis requires a balance between rapid regeneration and cell turnover. Little is known, however, about the factors determining tissue renewal and cell fate in the gastrointestinal tract.
GATA proteins are zinc finger transcription factors that regulate cellular development and differentiation. The GATA family contains six members; GATA-1, GATA-2, and GATA-3 function mainly in hematopoietic cell lineages [
1], whereas GATA-4, GATA-5, and GATA-6 are found in organs of endodermal origin [
2]. In the gastrointestinal tract, GATA-4 and GATA-6 are present from the onset of formation of the primitive gut tube through the organization of normal postnatal epithelium [
3‐
6]. GATA-4 is considered to be one of the first transcription factors binding to chromatin during early endodermal differentiation [
7]. This binding has been proposed to initiate the opening of the chromatin and enable the binding of other transcription factors to DNA [
8]. Mice with targeted deletion of
Gata4 or
Gata6 die during early embryonic development: GATA-6 is crucial in the development of visceral endoderm, whereas GATA-4 is needed for the formation of the heart tube [
4,
9].
GATA-4 and GATA-6 are both believed to facilitate the terminal differentiation of the epithelium of the intestinal villi [
10]. In mice chimeric for
Gata4 -/- and wild type cells, the gastric epithelial lineages were found to differentiate poorly during embryonic development [
6]. In mice harbouring a tissue-specific deletion of
Gata4 in the gut, jejunal gene expression was noted to change to the ileal-type, underscoring the role of GATA-4 in the development of the proximal small intestine [
11]. In the gastrointestinal tract, GATA proteins regulate a variety of target genes involved in digestive functions and tissue regeneration. For example, two genes expressed in enterocytes of the small intestine, lactase phlorizin hydrolase (LPH) and fatty acid binding protein (FABP), are regulated by GATA-4, GATA-5, and GATA-6 [
12‐
15]. Moreover, GATA factors are related to gastroprotective Trefoil Factor Family (TFF) peptides and mucin protein genes expressed in the stomach and colon mucosa [
16,
17].
In addition to normal growth, GATA proteins have been proposed to be associated with tumorigenesis in the adrenals, lungs and ovaries [
18‐
20]. GATA-6 upregulates expression of Indian hedgehog (Ihh) [
21]; the hedgehog signalling is known to be critical for proper gut morphogenesis [
22]. Ihh is present in mature human gastric and colon epithelium [
23,
24], and its expression is altered during carcinogenesis of the gastrointestinal tract [
23‐
25]. The role of Ihh in tumor biology, however, remains controversial. Ihh is believed to stimulate proliferation and induce carcinogenesis in the gastrointestinal tract [
25,
26], but it may also act as an antagonist of the Wnt-pathway to restrict tumor progression [
23].
In this study we compare the expression of GATA-4, GATA-6, and Ihh in normal and pathological human gastrointestinal tissue samples. We show that GATA-4, GATA-6 and Ihh have particular expression patterns in the gastrointestinal mucosa, depending on the segment in the longitudinal or crypt-villus axis, as well as the specific cell type. In addition, the expression patterns of these factors in gastrointestinal neoplasms differ from those in the normal gastrointestinal tract. We suggest that GATA-4 and GATA-6 may maintain normal tissue renewal and differentiation in mature gastrointestinal mucosa and that alterations in their expression accompany premalignant and malignant changes in the gut mucosa.
Methods
Normal samples
Normal gastrointestinal biopsy specimens were obtained during esophagogastroduodenoscopy and colonoscopy performed for diagnostic purposes. The specimens (Table
1) included tissue from gastric, duodenal, ileal, colonic and rectal mucosa. Most of the samples (37 out of 55) were collected from children. All biopsy specimens were diagnosed as morphologically normal by a pathologist.
Table 1
Patients' ages and the number of normal gastrointestinal samples as to the methods used
Stomach | 0.95 – 91.0 (15.4) | 11 | 6 | 10 | 7 | 7 |
Duodenum | 0.95 – 73.0 (11.6) | 16 | 9 | 14 | 8 | 8 |
Ileum | 6.08 – 76.0 (31.0) | 8 | 3 | 7 | 3 | 4 |
Colon | 5.90 – 76.0 (13.9) | 8 | 6 | 7 | 6 | 2 |
Rectum | 0.04 – 13.91 (6.89) | 6 | 9 | 3 | 8 | 1 |
Pathological samples
The pathological samples from distal esophagus and stomach were collected during routine esophagogastroduodenoscopy from adult patients with chronic and atrophic gastritis (Table
2). Esophageal biopsies contained intestinal metaplasia (also called Barrett's esophagus), a precancerous state of the esophageal epithelium. Neuroendocrine cell hyperplasia was found in three stomach samples. Colon and rectum samples were obtained in resections for adenomas and primary adenocarcinomas. Some of them contained dysplasia (n = 5) and invasive carcinoma (n = 2).
Table 2
Description of the neoplastic samples subjected to GATA-4, GATA-6 and Ihh immunohistochemistry
Esophagus | | | |
| Barrett's esophagus | 65 (55–83) | 9 |
Stomach | | | |
| Chronic gastritis, intestinal metaplasia | 67 (56–73) | 5 |
| Chronic gastritis, intestinal metaplasia, neuroendocrine cell hyperplasia | 52 (49–54) | 2 |
| Intestinal metaplasia, neuroendocrine cell hyperplasia | 69 | 1 |
Colon | | | |
| Dysplasia | 41 | 1 |
| Adenoma serratum, dysplasia | 77 | 1 |
| Adenoma tubulovillosum, dysplasia | 47 (28–73) | 3 |
| Adenocarcinoma, low grade | 54 (41–87) | 3 |
| Adenocarcinoma, moderate grade | 71 (47–79) | 5 |
| Adenocarcinoma, high grade | 76 (72–80) | 2 |
Rectum | | | |
| Adenocarcinoma, high grade | 83 | 1 |
| Adenocarcinoma, moderate grade | 79 | 1 |
Tissue preparation and ethical considerations
Tissue specimens, originally collected for diagnostic purposes, were fixed in formalin and embedded in paraffin for further investigations, then cut into 6-μm sections, coded, and evaluated; the evaluator had no knowledge of the specimen. The specimens used for in situ hybdization experiments were frozen in liquid nitrogen and stored at -70°C until used. The use of the samples in this study was approved by the Ethics Committee of the Hospital for Children and Adolescents and the Ethics Committee of the Department of Internal Medicine, Helsinki University Central Hospital, and the Finnish National Authority of Medicolegal Affairs.
In situ hybridization
Radioactive
in situ hybridization was performed on normal gastrointestinal samples (Table
1). Paraffin embedded tissue sections (n = 22) were deparaffinized, and frozen sections (n = 9) were fixed in 40 g/L paraformaldehyde in phosphate-buffered saline (PBS). We applied the procedure described earlier [
27]. Human GATA-4 and GATA-6 cDNAs were prepared as previously described [
28]. Tissue sections were incubated with antisense or sense riboprobes labeled with
33P (1.2 × 10
6 cpm, 1000–3000 Ci/mmol, Amersham Pharmacia Biotech, Arlington Heights, IL) in a total volume of 80 μl. The slides were assessed by three researchers independently and blinded under a dark field light microscope (Leica DMRXA microscope, Leica, Switzerland).
Immunohistochemistry
Deparaffinized sections of normal and pathological tissue (Tables
1 and
2) were dehydrated, and antigen retrieval was improved by microwave cooking for 20 min in 10 mM citric acid, pH 6. The endogenous peroxidase reaction was inhibited by treatment with 3 g/L of H
2O
2. The sections were then subjected to immunohistochemistry, using polyclonal goat anti-human GATA-4 (sc-1237, dilution 1:200) or Ihh (sc-1196, dilution 1:50) antibodies, or polyclonal rabbit anti-human GATA-6 antibody (sc-9055, dilution 1:50). The antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA). The specificity of the staining was assessed using preimmune serum or PBS instead of the primary antibody during the staining protocol. In addition, our earlier studies with consecutive samples for RNA in situ hybridization and immunohistochemistry on adrenal samples have revealed the reliability of the used anti-GATA-4 and anti-GATA-6 antibodies in human tissues [
28]. In some instances, GATA-6 gives a cytoplasmic staining as previously reported [
15]. Although cytoplasmic staining for GATA proteins usually has not been considered specific, there is also some evidence that GATA proteins are not always transported to the nucleus immediately after translation [
29]. The avidin-biotin immunoperoxidase system (Vectastain Elite ABC Kit, Vector laboratories, Burlingame, CA) and 3,3'-diaminobenzidine (Sigma-Aldrich, St. Louis, MO) were used to visualize antibody binding. The tissues were counterstained with Harris hematoxylin. The Alcian blue/periodic acid-Schiff staining method and hematoxylin-eosin staining were used to detect goblet and Paneth cells, respectively. These results were compared with GATA immunohistochemistry. All the slides were analysed under a light microscope (Leica DMRXA microscope) and reassessed by a pathologist.
Double immunostaining
The double-staining method was performed on normal paraffin-embedded sections. The sections were prepared as described above, with the following modifications: After staining for GATA-4 (sc-1237) or GATA-6 (sc-9055) with 3,3'-diaminobenzidine, the slides were incubated with the second primary antibody for 1 h at +37°C. The second primary antibody was either a polyclonal goat anti-human chromogranin A antibody (sc-1488, dilution 1:50, Santa Cruz Biotechnology) used to detect neuroendocrine cells in stomach, duodenum, and large intestine, or monoclonal anti-human hydrogen/potassium adenosine triphosphatase (H+/K+-ATPase) antibody against α (119102, dilution 1:50, Calbiochem®, EMD Chemicals Inc., Darmstadt, Germany) or β subunit (MA3-923, dilution 1:1000, Affinity BioReagents Inc., Golden, CO) to identify the parietal cells in the stomach. The immunoreactivity was visualised by Vector SG® (Vector Laboratories).
Discussion
Transcription factors play an important role in cell proliferation and differentiation, and consequently in tissue repair. We studied the expression of two GATA transcription factors in human gastrointestinal tract in detail. As our samples were derived from both children and adults, the wide age variation may have influenced the results. It is noteworthy, however, that in murine gastrointestinal tract, GATA-4 and GATA-6 expression patterns are rather stable from birth to adulthood [
30].
In mature gastrointestinal mucosa, new cells are continuously generated from multipotent stem cells. Although the exact location of the stem cells of the gastrointestinal mucosa has not been determined, it has been suggested that in the stomach they lie in the isthmus, whereas in the intestine they may be located deeper in the crypts. The proliferating descendants of the stem cells enter the differentiation pathway and migrate into their specific sites in the mucosa. The cells eventually undergo apoptosis and are shed into the gut lumen [
31]. It is of interest that the strongest GATA-6 expression occurs in the basal regions of the gut mucosa including cells with the highest proliferative capacity. Although GATA-6 expression has earlier been thought to decrease during enterocyte differentiation
in vitro [
10], we found GATA-6 in all mucosal layers, including the areas of highly differentiated cells. Ihh has been suggested to be regulated in part by GATA-6 [
21], and we find that the expression patterns of these two factors partly overlap in the gut. In contrast to GATA-6, GATA-4 was localized to more differentiated cells (this study) [
10]. In the murine small intestine, GATA-4 expression diminishes towards the villus tips the low expression thus associating with areas of apoptosis [
15]. In cardiac myocytes, GATA-4 is related to anti-apoptotic factors [
32], and its down-regulation is proposed to be essential for apoptosis [
33]. We therefore suggest that the absence of GATA-4 from the villus tip enables enterocyte apoptosis and exfoliation of senescent cells.
In chronic gastrointestinal inflammation, such as esophagitis and gastritis, the renewal of normal tissue is disturbed, possibly leading to neoplastic tissue growth [
34]. Interestingly, the expression of GATA-4, GATA-6 and Ihh appear to increase in two precancerous lesions such as Barrett's esophagus and intestinal metaplasias of the stomach. GATA-4 and GATA-6 are also expressed in hyperplastic neuroendocrine cells associated with atrophic gastritis. Some researchers have linked GATA-6 to normal murine neuroendocrine cells [
35,
36], but we detected neither GATA-4 nor GATA-6 in these cells (this study). The appearance of GATA factors in neuroendocrine cell hyperplasia raises the question of whether they contribute to the progression of neuroendocrine neoplasms. Interestingly, GATA factors have been shown to downregulate
HDC [
37] encoding a histamine synthesizing enzyme found in both normal and, in increasing amounts, in neoplastic neuroendocrine tissues [
38].
In contrast to metaplasias of the proximal gastrointestinal tract, GATA-4 is not present in colon tumors, whereas GATA-6 and Ihh are moderately expressed in colon adenomas, but to a much lesser extent in carcinomas. Our results suggest that histological tumor grade does not significantly correlate with the level of expression of GATA-6 in cancer cells, although earlier
in vitro studies have suggested that GATA-6 expression is strongest in the most undifferentiated colon carcinoma cells [
10]. In our preliminary analyses, we found that intense GATA-6 immunoreactivity is characteristic of the border regions of malignant tissue and the invasive parts of the carcinoma. This may well be due to stromal signals that induce GATA-6 in the adjacent tumor regions.
The expression patterns of GATA-4 and GATA-6 in the longitudinal and crypt-villus axes are in accordance with the results of earlier studies on murine gastrointestinal tract [
15]. In human fetuses, GATA-4 was found in the small intestine [
39], and this expression is sustained in mature mucosa as well (this study). Also an earlier study based on RT-PCR analysis demonstrated the absence of GATA-4 from colon, and its presence in stomach [
40]. A gene for hydrogen/potassium adenosine triphosphatase (H+/K+ ATPase) in the stomach, responsible for acid production in the parietal cells, is regulated by the gastrointestinal GATA factors [
41]. In the parietal cells, GATA-6 positivity varied from one cell to another. This may reflect the fact that the structure and activity of the parietal cells depend on their developmental stage and location in the glands [
31]. In our study, Ihh expression was intense in normal gastric glands, whereas Fukaya et al. [
24] found Ihh only in gastric pits. The same Ihh antibodies were used in both studies, but the samples in Fukaya's study were neoplastic and their matched tissues. These differences are likely to explain the discrepancies between the two reports.
GATA proteins have been suggested to regulate genes encoding for TFF and mucin proteins [
16,
17] which protect the mucosa from harmful exogenous agents and are related to abnormal tissue growth and carcinogenesis [
42‐
44]. It is of interest that both GATA-4 and GATA-6 proteins are present in TFF-expressing pit and surface epithelial cells. We detected GATA-6 also in human goblet cells, and others have found GATA-4 in murine goblet cells that express the mucin protein MUC2 [
17]. Furthermore, TFF and mucin proteins have been shown to be present in esophageal and gastric metaplasias [
45‐
47], similarly to GATA-4 and GATA-6 (this study). Particularly MUC2 expression in Barrett's metaplasia is considered to indicate a higher risk for carcinoma [
46]. Collectively, these data support the interrelationship of GATA proteins, TFF, and mucins in the gastrointestinal endoderm.
A previous study suggested that inactivation of the
Gata4 gene by methylation could be crucial during carcinogenesis [
48]. It is tempting to speculate that GATA-4, in addition to promoting cellular differentiation in the human gastrointestinal tract, is also involved in the suppression of abnormal growth in the proximal gastrointestinal tract. When GATA-4 is inactivated by methylation, the fate of the cells may proceed towards malignant alterations. Likewise, the role of GATA-6 in neoplasias is controversial. In vascular smooth muscle cells, GATA-6 inhibits injury induced hyperplasia [
49]. It is noteworthy that GATA-6 is present in adrenocortical adenomas, but diminishes in carcinomas, suggesting that also
Gata6 may become methylated during tumorigenesis [
50]. GATA-6 has been suggested to induce cell cycle arrest [
51], to inhibit apoptosis and induce malignant cell growth [
52]. Our preliminary results suggest high expression of GATA-6 in the invasive edges of the carcinomas. The enhanced GATA-6 action in these tumor areas may be linked to uncontrolled growth of the tumor cells. More detailed studies are, however, required to establish the role of GATA-6 in the gastrointestinal tumor growth.
Competing interests
The author(s) declare that they have no competing interests.
Authors' contributions
HH designed the study, performed the experiments, analysed the data and was responsible for writing the paper. MW-O participated in the study design, collection and interpretation of the data, and in writing the paper. KL, MM and ES participated in the collection of the patient samples and data as well as in drafting the manuscript. LCA participated in the study design, collection, analysis and interpretation of the data, and in finalizing the manuscript. MH designed and coordinated the study, interpreted the data, and was responsible for writing the paper. All authors have read and approved the final manuscript.